Nymox Pharmaceutical Corporation NYMXF
0.02 USD -0.01 (-33.33%)
Nov 4, 2026, 1:42 PM EST
0.02 Day range 0.02
0.0002 52-week range 0.1999
- YTD
- -50.25%
- 1 year
- -83.55%
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -6.65M | -12.50M | -11.72M | -13.32M | -10.64M | |
| -6.58M | -12.54M | -11.74M | -13.16M | -10.59M | |
| -0.07 | -0.15 | -0.16 | -0.19 | -0.18 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 1.40M | 830.00K | 3.61M | 5.24M | 7.95M | |
| 1.63M | 1.44M | 4.34M | 5.49M | 8.08M | |
| 2.11M | 1.95M | 2.20M | 2.04M | 1.07M | |
| 173.00K | 391.00K | 426.00K | 147.00K | 0 | |
| -482.00K | -506.00K | 2.15M | 3.45M | 7.00M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| -5.21M | -9.82M | -10.04M | -7.43M | -7.80M | |
| 5.78M | 7.04M | 8.42M | 4.72M | 14.93M | |
| 573.00K | -2.78M | -1.63M | -2.71M | 7.09M |